CompoAtlas

MEMORY & MENTAL ACUITY

Natural health product licensed in Canada

Other names
Sharp Thinking Ultra
Licence holder
Vitamins Direct oa W.T. Rawleigh Co.
NPN or DIN-HM
80030223
Status
Inactive licence
Licence date
6 March 2012
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
L-Tyrosine

Source : L-Tyrosine

100 mgNot calculated
Acide pantothénique

Source : D-Pantothénate de calcium

25 mg50,000 µg
Lécithine

Source : Huile de soja

Potency : 5 mg phosphatidylserine

25 mgNot calculated
Vitamine B12

Source : Cyanocobalamine

25 mcg50 µg

Non-medicinal ingredients

Acide stéarique, silice, Phosphate de calcium, dibasique, Croscarmellose de sodium, Pharmaceutical Glaze, Stéarate de magnésium, Microcrystalline cellulose

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Comprimé1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor in the maintenance of good health. Helps in tissue formation and to produce red blood cells. Helps to enhance memory and cognitive function in adults.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80030223

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line